Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis
Hospitalizations due to medical and surgical complications of substance use disorder (SUD) are rising. Most hospitals lack systems to treat SUD, and most people with SUD do not engage in treatment after discharge.
Determine the effect of a hospital-based addiction medicine consult service, the Improving Addiction Care Team (IMPACT), on post-hospital SUD treatment engagement.
Cohort study using multivariable analysis of Oregon Medicaid claims comparing IMPACT patients with propensity-matched controls.
18–64-year-old Oregon Medicaid beneficiaries with SUD, hospitalized at an Oregon hospital between July 1, 2015, and September 30, 2016. IMPACT patients (n = 208) were matched to controls (n = 416) using a propensity score that accounted for SUD, gender, age, race, residence region, and diagnoses.
IMPACT included hospital-based consultation care from an interdisciplinary team of addiction medicine physicians, social workers, and peers with lived experience in recovery. IMPACT met patients during hospitalization; offered pharmacotherapy, behavioral treatments, and harm reduction services; and supported linkages to SUD treatment after discharge.
Healthcare Effectiveness Data and Information Set (HEDIS) measure of SUD treatment engagement, defined as two or more claims on two separate days for SUD care within 34 days of discharge.
Only 17.2% of all patients were engaged in SUD treatment before hospitalization. IMPACT patients engaged in SUD treatment following discharge more frequently than controls (38.9% vs. 23.3%, p < 0.01; aOR 2.15, 95% confidence interval [CI] 1.29–3.58). IMPACT participation remained associated with SUD treatment engagement when limiting the sample to people who were not engaged in treatment prior to hospitalization (aOR 2.63; 95% CI 1.46–4.72).
Hospital-based addiction medicine consultation can improve SUD treatment engagement, which is associated with reduced substance use, mortality, and other important clinical outcomes. National expansion of such models represents an opportunity to address an enduring gap in the SUD treatment continuum.
KEY WORDSsubstance-related disorders hospitalization substance use treatment Medicaid
Authors would like to acknowledge the entire IMPACT clinical and research teams. Specifically, they would like to thanks Alisa Patten and Devin Collins for their contributions to this paper, and Dr Melissa Weimer, Daren Ford, and O'Nesha Cochran Dumas for their dedication as the original IMPACT clinical team
This study was funded by the OHSU School of Medicine. IMPACT is funded by Oregon Health & Science University and CareOregon. The OHSU School of Medicine funded IMPACT evaluation activities. Dr. Korthuis’ time was supported by the National Institutes of Health and National Institute on Drug Abuse (UG3DA044831, UG1DA015815). This publication was made possible with support from the Oregon Clinical and Translational Research Institute (OCTRI), grant number UL1TR002369 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.
Compliance with Ethical Standards
This study was approved by the Oregon Health & Science University (OHSU) Institutional Review Board.
Conflict of Interest
The authors declare that they do not have a conflict of interest.
The funders had no role in the design, conduct, and reporting of this study.
- 4.Weiss A, Elixhauser A, Barrett M, Steiner C, Bailey M, O’Malley L. Opioid-related inpatient stays and emergency department visits by state, 2009-2014. Statistical Brief #219. Healthcare Cost and Utilization Project. 2016. https://www.hcup-us.ahrq.gov/reports/statbriefs/sb219-Opioid-Hospital-Stays-ED-Visits-by-State.jsp. Accessed May 21, 2019.
- 6.Schranz AJ, Fleischauer A, Chu VH, Wu LT, Rosen DL. Trends in drug use-associated infective endocarditis and heart valve surgery, 2007 to 2017: a study of statewide discharge data. Ann Intern Med. 2018 Dec 4. https://doi.org/10.7326/M18-2124
- 8.Englander H, Collins D, Perry SP, Rabinowitz M, Phoutrides E, Nicolaidis C. “We’ve learned it’s a medical illness, not a moral choice”: qualitative study of the effects of a multicomponent addiction intervention on hospital providers’ attitudes and experiences. J Hosp Med 2018;13(11):752–8.Google Scholar
- 18.Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2014;(2):CD002207.Google Scholar
- 19.Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N. Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database Syst Rev 2016;(5):Cd011117.Google Scholar
- 31.Englander H, Gregg J, Gullickson J, Cochran O, Colasurdo C, Alla J, et al. Recommendations for intergrating peer mentors in hospital-based addiction care. Subst Abus In press. https://doi.org/10.1080/08897077.2019.1635968
- 33.Priest KC. Hospital-based services for opioid use disorder: a study of supply-side attributes. Dissertation and Theses. 2019. Paper 4829. Available from: https://pdxscholar.library.pdx.edu/open_access_etds/4829.
- 35.Kronick R, Gilmer T, Dreyfus T, Lee L. Improving health-based payment for Medicaid beneficiaries: CDPS. Health Care Financ Rev 2000;21(3):29–64.Google Scholar
- 36.National Committee for Quality Assurance. Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment (IET). 2017. [Cited 2019 June 7]. Available from: https://www.ncqa.org/hedis/measures/initiation-and-engagement-of-alcohol-and-other-drug-abuse-or-dependence-treatment/.
- 37.Centers for Medicare & Medicaid Services. ICD-10-CM/PCS MS-DRG v34.0 Definitions Manual. [cited 2019 Apr 12]. Available from: https://www.cms.gov/ICD10Manual/version34-fullcode-cms/fullcode_cms/P0001.html.
- 40.Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2017 National Survey on Drug Use and Health (HHS Publication No. SMA 18-5068, NSDUH Series H-53). Rockville, MD 2018. [cited 2019 Apr 12]. Available from: https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.htm.
- 49.Weiss AJ, Heslin KC. Payers of opioid-related inpatient stays and emergency department visits nationally and by state, 2010 and 2015. HCUP Statistical Brief #239. Agency for Healthcare Research and Quality, Rockville (MD). 2018. [cited 2019 Apr 12]. Available from: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb239-Opioid-Payer-Hospital-Stays-ED-Visits-by-State.jsp.